Shares of Methanex Corporation (NASDAQ:MEOH - Get Free Report) TSE: MX were down 4.2% during trading on Tuesday . The company traded as low as $56.87 and last traded at $57.26. Approximately 79,595 shares changed hands during trading, a decline of 94% from the average daily volume of 1,249,122 shares. The stock had previously closed at $59.75.
Wall Street Analysts Forecast Growth
A number of research firms recently commented on MEOH. Canadian Imperial Bank of Commerce raised their price objective on shares of Methanex from $52.00 to $59.00 and gave the company a "neutral" rating in a research note on Tuesday, March 17th. Scotiabank reiterated an "outperform" rating on shares of Methanex in a research report on Wednesday, January 21st. UBS Group boosted their price objective on Methanex from $60.00 to $70.00 and gave the stock a "buy" rating in a research note on Thursday, April 9th. Royal Bank Of Canada lowered Methanex from an "outperform" rating to a "sector perform" rating and upped their price objective for the company from $55.00 to $65.00 in a report on Thursday, April 2nd. Finally, Zacks Research lowered Methanex from a "hold" rating to a "strong sell" rating in a report on Monday, March 16th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Methanex currently has a consensus rating of "Moderate Buy" and an average target price of $55.50.
Get Our Latest Stock Analysis on Methanex
Methanex Stock Performance
The stock has a market cap of $4.41 billion, a price-to-earnings ratio of 50.49 and a beta of 0.56. The company's 50-day simple moving average is $53.71 and its 200-day simple moving average is $44.53. The company has a quick ratio of 1.37, a current ratio of 2.06 and a debt-to-equity ratio of 0.99.
Methanex (NASDAQ:MEOH - Get Free Report) TSE: MX last released its quarterly earnings data on Thursday, March 5th. The specialty chemicals company reported ($0.14) earnings per share for the quarter, missing the consensus estimate of $0.81 by ($0.95). The company had revenue of $968.81 million for the quarter, compared to the consensus estimate of $1.03 billion. Methanex had a return on equity of 5.35% and a net margin of 2.21%.The business's revenue was up 2.1% compared to the same quarter last year. During the same period in the prior year, the business earned $1.24 earnings per share. Analysts predict that Methanex Corporation will post 4.32 EPS for the current fiscal year.
Methanex Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th were given a $0.185 dividend. This represents a $0.74 annualized dividend and a dividend yield of 1.3%. The ex-dividend date of this dividend was Tuesday, March 17th. Methanex's dividend payout ratio (DPR) is 65.49%.
Institutional Investors Weigh In On Methanex
Hedge funds have recently made changes to their positions in the company. NewEdge Advisors LLC boosted its position in shares of Methanex by 33.3% in the third quarter. NewEdge Advisors LLC now owns 2,000 shares of the specialty chemicals company's stock worth $80,000 after buying an additional 500 shares during the period. Value Partners Investments Inc. increased its holdings in Methanex by 3.0% in the third quarter. Value Partners Investments Inc. now owns 19,842 shares of the specialty chemicals company's stock worth $789,000 after buying an additional 570 shares during the last quarter. Parkside Financial Bank & Trust raised its holdings in shares of Methanex by 61.0% during the 4th quarter. Parkside Financial Bank & Trust now owns 2,143 shares of the specialty chemicals company's stock valued at $85,000 after purchasing an additional 812 shares in the last quarter. Franklin Resources Inc. lifted its position in shares of Methanex by 8.2% in the fourth quarter. Franklin Resources Inc. now owns 10,706 shares of the specialty chemicals company's stock worth $425,000 after buying an additional 813 shares during the last quarter. Finally, Amundi lifted its holdings in Methanex by 3.9% in the 1st quarter. Amundi now owns 22,791 shares of the specialty chemicals company's stock worth $800,000 after purchasing an additional 848 shares during the last quarter. Hedge funds and other institutional investors own 73.49% of the company's stock.
Methanex Company Profile
(
Get Free Report)
Methanex Corporation is a Vancouver, Canada–based company and one of the world's largest producers and suppliers of methanol. The company manufactures methanol, a key feedstock for a wide range of chemical products and industrial applications. Methanex markets its product to customers in energy, plastics, paints and coatings, and various chemical sectors, positioning the company as a critical link in the global supply chain for basic chemicals.
The company's core product, methanol, serves as a building block for downstream chemicals such as formaldehyde, acetic acid and methyl tertiary butyl ether (MTBE).
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Methanex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Methanex wasn't on the list.
While Methanex currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.